(Q37893637)

24 August 2017

1 reference

title

Issues in the management of challenging behaviours of adults with autism spectrum disorder (English)

1 reference

24 August 2017

main subject

autism spectrum disorder

0 references

0 references

3

Jill C Fodstad

1 reference

24 August 2017

1

Johnny L Matson

1 reference

24 August 2017

2

Megan Sipes

1 reference

24 August 2017

Mary E Fitzgerald

4

1 reference

24 August 2017

publication date

1 July 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

25

1 reference

24 August 2017

issue

7

1 reference

24 August 2017

page(s)

597-606

1 reference

https://scigraph.springernature.com/pub.10.2165/11591700-000000000-00000

24 August 2017

exact match

0 references

cites work

Determining treatment outcome in early intervention programs for autism spectrum disorders: A critical analysis of measurement issues in learning based interventions

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

National autism prevalence trends from United States special education data

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

The form and function of challenging behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

The prevalence of challenging behaviors: a total population study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

The effects of intellectual functioning and autism severity on outcome of early behavioral intervention for children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Problem behavior interventions for young children with autism: a research synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Challenging behavior and co-morbid psychopathology in adults with intellectual disability and autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Correlates of restraint use in an institutional population: a replication

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Increased risk of injury in children with developmental disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Comparing functional assessment methodologies: a quantitative synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Pharmacotherapy of irritability in pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Social skills interventions for individuals with autism: evaluation for evidence-based practices within a best evidence synthesis framework

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Pivotal areas in intervention for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Applied behavior analytic intervention for autism in early childhood: meta-analysis, meta-regression and dose-response meta-analysis of multiple outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Efficacy of behavioral interventions for reducing problem behavior in persons with autism: a quantitative synthesis of single-subject research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Behavioral treatment of chronic skin-picking in individuals with developmental disabilities: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Targeted treatments for symptom domains in child and adolescent autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Case series: use of ziprasidone for maladaptive symptoms in youths with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Pharmacologic treatment for the core deficits and associated symptoms of autism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Psychopharmacology in autism: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Developing drugs for core social and communication impairment in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

An Examination of Psychotropic Medication Side Effects: does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Clinical management of adolescents with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

A validity study on the Questions About Behavioral Function (QABF) Scale: predicting treatment success for self-injury, aggression, and stereotypies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Episodic psychiatric disorders in teenagers with learning disabilities with and without autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Young adult outcome of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: a review of current and potentially promising treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591700-000000000-00000

Autism spectrum disorder grown up: a chart review of adult functioning.

21 January 2018

1 reference

12 December 2020

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS).

1 reference

12 December 2020

10.2165/11591700-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

24 August 2017

1011508513

0 references

1 reference